Al Fin, You Sexy Thing!

04 May 2010

Can Science Help Premature Ejaculators?

Priligy (Dapoxetine) is an antidepressant that is being marketed in Europe by Janssen-Cilag to treat premature ejaculation.
Originally marketed as an antidepressant, Priligy is a short-acting selective serotonin reuptake inhibitor that works by altering the levels of serotonin - the hormone responsible for ejaculation - in the brain to give men a greater degree of control, and trials in more than 6,000 patients showed that it can increase the time to ejaculation by a factor of three.
Many drug analysts expect Priligy to eventually rival Viagra in sales and social impact. In the case of Priligy, the female partner can benefit as much as or more than the male.
Priligy which is owned by one of Johnson & Johnson’s subsidiaries namely the ALZA Corporation has received full approval as a prescription medication in many European countries including the UK. It continues to be tested for full approval by the Food & Drug Administration of America. _ukmedix

No one really knows how long a man should last before he comes. Science cannot answer that question, because the answer changes for each session of love-making. Sometimes, a woman would just like for the man to get it over with, already. Other times, when she is particularly receptive, she would like for the peak experience to go on and on . . . .

It is not optimal to make everything a medical problem, but at least with reliable drugs -- such as are becoming available for sexual dysfunctions -- a person has a ready means of getting help.

Labels: ,


Post a Comment

Subscribe to Post Comments [Atom]

<< Home

Newer Posts Older Posts